Firth SM and Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824–854
Article CAS PubMed Google Scholar
Monzavi R and Cohen P (2002) IGFs and IGFBPs: role in health and disease. Best Pract Res Clin Endocrinol Metab 16: 433–437
Article CAS PubMed Google Scholar
Dupont J and LeRoith D (2001) Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction. Horm Res 55 (Suppl 2): S22–S26
Google Scholar
Lupu F et al. (2001) Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229: 141–162
Article CAS PubMed Google Scholar
Dominici FP et al. (2000) Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol 166: 579–590
Article CAS PubMed Google Scholar
Coschigano KT et al. (2000) Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141: 2608–2613
Article CAS PubMed Google Scholar
Liu JL et al. (2004) Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab 287: E405–E413
Article CAS PubMed Google Scholar
Guo Y et al. (2005) Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene deficient mice. Endocrinology 146: 2602–2609
Article CAS PubMed Google Scholar
Yakar S et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96: 7324–7329
Article CAS PubMed PubMed Central Google Scholar
Yakar S et al. (2001) Liver-specific Igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50: 1110–1118
Article CAS PubMed Google Scholar
Yakar S et al. (2004) Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 113: 96–105
Article CAS PubMed PubMed Central Google Scholar
Clemmons DR et al. (2005) Recombinant, nonglycosylated human insulin-like growth factor-binding protein-3 (IGFBP-3) is degraded preferentially after administration to type II diabetics, resulting in increased endogenous glycosylated IGFBP-3. J Clin Endocrinol Metab 90: 6561–6568
Article CAS PubMed Google Scholar
Haluzik M et al. (2003) Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 52: 2483–2489
Article CAS PubMed Google Scholar
Mauras N et al. (2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85: 1686–1694
CAS PubMed Google Scholar
Rose DR and Clemmons DR (2002) Growth hormone receptor antagonist improves insulin resistance in acromegaly. Growth Horm IGF Res 12: 418–424
Article CAS PubMed Google Scholar
Di Cola G et al. (1997) Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 99: 2538–2544
Article CAS PubMed PubMed Central Google Scholar
Ranke MB (2005) Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance. Trends Endocrinol Metab 16: 190–197
Article CAS PubMed Google Scholar
Yuen K et al. (2004) Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults. J Clin Endocrinol Metab 89: 3956–3964
Article CAS PubMed Google Scholar
Yuen K et al. (2002) The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. J Clin Endocrinol Metab 87: 1989–1995
Article CAS PubMed Google Scholar
Johannsson G et al. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82: 727–734
CAS PubMed Google Scholar
Jorgensen JO et al. (1994) Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 130: 224–228
Article CAS PubMed Google Scholar
Bengtsson BA et al. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76: 309–317
CAS PubMed Google Scholar
Kim KR et al. (1999) Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm Res 51: 78–84
CAS PubMed Google Scholar
Goodman HM (1968) Growth hormone and the metabolism of carbohydrate and lipid in adipose tissue. Ann N Y Acad Sci 148: 419–440
Article CAS PubMed Google Scholar
Raben MS and Hollenberg CH (1959) Effect of growth hormone on plasma fatty acids. J Clin Invest 38: 484–488
Article CAS PubMed PubMed Central Google Scholar
Richelsen B (1997) Action of growth hormone in adipose tissue. Horm Res 48 (Suppl 5): S105–S110
Article Google Scholar
Rudling M et al. (1992) Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89: 6983–6987
Article CAS PubMed PubMed Central Google Scholar
Oscarsson J et al. (1999) GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol 160: 247–255
Article CAS PubMed Google Scholar
Norrelund H et al. (2003) The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. J Clin Endocrinol Metab 88: 4371–4378
Article CAS PubMed Google Scholar
Segerlantz M et al. (2001) Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 86: 5813–5818
Article CAS PubMed Google Scholar
Zick Y (2004) Uncoupling insulin signalling by serine/threonine phosphorylation: a molecular basis for insulin resistance. Biochem Soc Trans 32: 812–816
Article CAS PubMed Google Scholar
Clemmons DR (2004) The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 113: 25–27
Article CAS PubMed PubMed Central Google Scholar
Heffernan M et al. (2001) The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β(3)-AR knock-out mice. Endocrinology 142: 5182–5189
Article CAS PubMed Google Scholar
Hollenga C et al. (1991) Relationship between lipolysis and cyclic AMP generation mediated by atypical β-adrenoceptors in rat adipocytes. Br J Pharmacol 102: 577–580
Article CAS PubMed PubMed Central Google Scholar
Lafontan M and Berlan M (1993) Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057–1091
CAS PubMed Google Scholar
Susulic VS et al. (1995) Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 270: 29483–29492
Article CAS PubMed Google Scholar
Rudman D et al. (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323: 1–6
Article CAS PubMed Google Scholar
Taaffe DR et al. (1994) Regional fat distribution by dual-energy X-ray absorptiometry: comparison with anthropometry and application in a clinical trial of growth hormone and exercise. Clin Sci (Lond) 87: 581–586
Article CAS Google Scholar
Taaffe DR et al. (2001) Recombinant human growth hormone, but not insulin-like growth factor-I, enhances central fat loss in postmenopausal women undergoing a diet and exercise program. Horm Metab Res 33: 156–162
Article CAS PubMed Google Scholar
Scavo LM et al. (2004) Insulin-like growth factor-I stimulates both cell growth and lipogenesis during differentiation of human mesenchymal stem cells into adipocytes. J Clin Endocrinol Metab 89: 3543–3553
Article CAS PubMed Google Scholar
Huang Y et al. (2004) Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol 18: 1471–1485
Article CAS PubMed Google Scholar
Zizola CF et al. (2002) Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes. Biochimie 84: 975–980
Article CAS PubMed Google Scholar
Albert SG and Mooradian AD (2004) Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity. J Clin Endocrinol Metab 89: 695–701
Article CAS PubMed Google Scholar
Franco C et al. (2005) Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab 90: 1466–1474
Article CAS PubMed Google Scholar
Horber FF and Haymond MW (1990) Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 86: 265–272
Article CAS PubMed PubMed Central Google Scholar
Mauras N and Haymond MW (2005) Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15: 19–27
Article CAS PubMed Google Scholar
Fryburg DA and Barrett EJ (1999) Physiological effects and potential applications of GH and IGF-I. Diabetes Nutr Metab 12: 329–336
CAS PubMed Google Scholar
Turkalj I et al. (1992) Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75: 1186–1191
CAS PubMed Google Scholar
Louard RJ et al. (1992) Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J Clin Invest 90: 2348–2354
Article CAS PubMed PubMed Central Google Scholar
Biolo G et al. (1995) Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest 95: 811–819
Article CAS PubMed PubMed Central Google Scholar
Wilmore DW (1999) The use of growth hormone in severely ill patients. Adv Surg 33: 261–274
CAS PubMed Google Scholar
Mulligan K et al. (1999) Use of growth hormone and other anabolic agents in AIDS wasting. JPEN J Parenter Enteral Nutr 23 (Suppl 6): S202–S209
Article CAS PubMed Google Scholar
Haffner D et al. (2000) Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med 343: 923–930
Article CAS PubMed Google Scholar
Mauras N et al. (2002) Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism 51: 127–135
Article CAS PubMed Google Scholar
Takala J et al. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341: 785–792
Article CAS PubMed Google Scholar
Clemmons DR (1993) Use of growth hormone and insulin-like growth factor I in catabolism that is induced by negative energy balance. Horm Res 40: 62–67
Article CAS PubMed Google Scholar
Mauras N (1995) Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects. J Clin Endocrinol Metab 80: 2633–2637
CAS PubMed Google Scholar
Mulligan K and Schambelan M (2002) Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol 85: 151–159
Article PubMed Google Scholar
Frost RA et al. (1996) Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin Endocrinol (Oxf) 44: 501–514
Article CAS Google Scholar
Unterman TG (1993) Insulin-like growth factor binding protein-1: identification, purification, and regulation in fetal and adult life. Adv Exp Med Biol 343: 215–226
Article CAS PubMed Google Scholar
Arslanian SA et al. (1993) Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type 1 diabetes. Diabet Med 10: 833–838
Article CAS PubMed Google Scholar
Press M et al. (1984) Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med 310: 810–815
Article CAS PubMed Google Scholar
Baxter RC (1995) Insulin-like growth factor binding proteins as glucoregulators. Metabolism 44: 12–17
Article CAS PubMed Google Scholar
Hussain MA et al. (1993) Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 92: 2249–2256
Article CAS PubMed PubMed Central Google Scholar
Rennert NJ et al. (1993) Metabolic effects of rhIGF-1 in normal human subjects. Adv Exp Med Biol 343: 311–318
Article CAS PubMed Google Scholar
Clemmons DR et al. (2000) The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85: 1518–1524
CAS PubMed Google Scholar
Acerini CL et al. (1998) Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus. Metabolism 47: 1481–1489
Article CAS PubMed Google Scholar
Morrow LA et al. (1994) Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab 79: 205–210
CAS PubMed Google Scholar
Moses AC et al. (1996) Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 45: 91–100
Article CAS PubMed Google Scholar
Zenobi PD et al. (1992) Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 89: 1908–1913
Article CAS PubMed PubMed Central Google Scholar